Introduction to a How I Treat series on management of high-risk patients following allogeneic transplant

Free article

Editorial

Robert Zeiser. Blood. 2023.

Free article

. 2023 Jan 5;141(1):1.

doi: 10.1182/blood.2022018003.

No abstract available

Comment on

How I treat with maintenance therapy after allogeneic HCT.
DeFilipp Z, Chen YB. DeFilipp Z, et al. Blood. 2023 Jan 5;141(1):39-48. doi: 10.1182/blood.2021012412. Blood. 2023. PMID: 35231083
How I prevent GVHD in high-risk patients: posttransplant cyclophosphamide and beyond.
Rimando J, McCurdy SR, Luznik L. Rimando J, et al. Blood. 2023 Jan 5;141(1):49-59. doi: 10.1182/blood.2021015129. Blood. 2023. PMID: 35405017 Review.
How I treat high-risk acute myeloid leukemia using preemptive adoptive cellular immunotherapy.
Biederstädt A, Rezvani K. Biederstädt A, et al. Blood. 2023 Jan 5;141(1):22-38. doi: 10.1182/blood.2021012411. Blood. 2023. PMID: 35512203 Free PMC article.